Position in ATNM
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$334
-$5 QoQ
Shares Held
341
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 47 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATNM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $164,908 across 8 Biotechnology names. ATNM ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
|
1,000 | $104,620 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
612 | $33,623 | |
| 3 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,000 | $16,970 | |
| 4 | CRMD |
CorMedix Inc.
|
610 | $4,788 | |
| 5 | EXEL |
Exelixis, Inc.
|
80 | $4,352 | |
| 6 | ATNM |
Actinium Pharmaceuticals, Inc.
This page
|
341 | $334 | |
| 7 | ELDN |
Eledon Pharmaceuticals, Inc.
|
35 | $137 | |
| 8 | INO |
Inovio Pharmaceuticals, Inc.
|
77 | $84 |
All Filings in ATNM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334 | 341 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $339 | 341 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $463 | 341 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $545 | 341 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $477 | 341 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $549 | 341 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||